AICDA (NM_020661) Human Recombinant Protein

CAT#: TP762070

Purified recombinant protein of Human activation-induced cytidine deaminase (AICDA),full length, with N-terminal His tag, expressed in E. coli, 50ug

Product Images

Specifications

Product Data

• Species: Human
• Expression Host: E. coli
• Expression cDNA Clone or AA Sequence:
  Protein Sequence

  A DNA sequence encoding human full-length AICDA
• Tag: N-His
• Predicted MW: 23.8 kDa
• Concentration: >0.05 µg/µL as determined by microplate BCA method
• Purity: > 80% as determined by SDS-PAGE and Coomassie blue staining
• Buffer: 50 mM Tris-HCl, pH 8.0, 8 M urea
• Note: For testing in cell culture applications, please filter before use. Note that you may experience some loss of protein during the filtration process.
• Storage: Store at -80°C.
• Stability: Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles.

Reference Data

• RefSeq: NP_065712
• Locus ID: 57379
• UniProt ID: Q9GZX7, Q546Y9, Q7Z599
• Cytogenetics: 12p13.31
• Refseq Size: 2794
• Refseq ORF: 594
• Synonyms: AID; ARP2; CDA2; HEL-S-284; HIGM2
• Summary: This gene encodes a RNA-editing deaminase that is a member of the cytidine deaminase family. AICDA is specifically expressed and active in germinal center-like B cells. In the germinal center, AICDA is involved in somatic hypermutation, gene conversion, and class-switch recombination of immunoglobulin genes. An epigenetic role in neoplastic transformation and lymphoma progression has been experimentally ascribed to AICDA using mouse models. Defects in this gene are the cause of autosomal recessive hyper-IgM immunodeficiency syndrome type 2 (HIGM2). [provided by RefSeq, Jul 2020]
• Protein Families: Druggable Genome
• Protein Pathways: Primary immunodeficiency